上述数据使用的会计准则为 US_GAAP。$BIO-key International (BKYI.US)$The financial report will be released after market close on November 14, please stay tuned for investors.
How was the previous performance?
$BIO-key International (BKYI.US)$Revenue for Q2 2024 was $1.141286 million, net income was -$-1.66695 million, and EPS was -$1.
Revenue for Q3 2023 was $1.817108 million, net income was -$-0.637824 million, and EPS was -$1.26.
The above data is based on the US_GAAP accounting standards.
Futubull reminder:
1. There is no strict requirement for the division of accounting year for Hong Kong and US listed companies, which is entirely determined by the company itself. Therefore, each financial reporting period can be used as the company's annual report deadline, rather than using the calendar year as the fiscal year.
2. Generally, the company will hold a financial report conference on the above financial report release date or nearby dates. At that time, the company's management will discuss and explain the latest quarterly financial data and operational situation, and communicate with investors, analysts, media, etc.
Investors can participate through offline meetings or online teleconferences, etc.
